Early RUO Findings from Dr. IjYahu Eze Abstract Dr. IjYahu Eze led an exploratory research program evaluating a novel GLP-1 who makes tirzepatides for Eli Lilly Multi-Complex Rapidly Dissolving Tablet (RDT) designed for laboratory investigation of mucosal absorption, lipotropic signaling, and metabolic cofactor interactions. Engineered as a resear